CCCTC-Binding Factor Recruitment to the Early Region of the Human Papillomavirus 18 Genome Regulates Viral Oncogene Expression

ABSTRACT Host cell differentiation-dependent regulation of human papillomavirus (HPV) gene expression is required for productive infection. The host cell CCCTC-binding factor (CTCF) functions in genome-wide chromatin organization and gene regulation. We have identified a conserved CTCF binding site in the E2 open reading frame of high-risk HPV types. Using organotypic raft cultures of primary human keratinocytes containing high-risk HPV18 genomes, we show that CTCF recruitment to this conserved site regulates viral gene expression in differentiating epithelia. Mutation of the CTCF binding site increases the expression of the viral oncoproteins E6 and E7 and promotes host cell proliferation. Loss of CTCF binding results in a reduction of a specific alternatively spliced transcript expressed from the early gene region concomitant with an increase in the abundance of unspliced early transcripts. We conclude that high-risk HPV types have evolved to recruit CTCF to the early gene region to control the balance and complexity of splicing events that regulate viral oncoprotein expression. IMPORTANCE The establishment and maintenance of HPV infection in undifferentiated basal cells of the squamous epithelia requires the activation of a subset of viral genes, termed early genes. The differentiation of infected cells initiates the expression of the late viral transcripts, allowing completion of the virus life cycle. This tightly controlled balance of differentiation-dependent viral gene expression allows the virus to stimulate cellular proliferation to support viral genome replication with minimal activation of the host immune response, promoting virus productivity. Alternative splicing of viral mRNAs further increases the complexity of viral gene expression. In this study, we show that the essential host cell protein CTCF, which functions in genome-wide chromatin organization and gene regulation, is recruited to the HPV genome and plays an essential role in the regulation of early viral gene expression and transcript processing. These data highlight a novel virus-host interaction important for HPV pathogenicity.

[1]  J. Rasko,et al.  CTCF and BORIS in genome regulation and cancer. , 2014, Current opinion in genetics & development.

[2]  S. Swaminathan,et al.  CTCF and Rad21 Act as Host Cell Restriction Factors for Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Lytic Replication by Modulating Viral Gene Transcription , 2014, PLoS pathogens.

[3]  I. Tempera,et al.  Epigenetic Deregulation of the LMP1/LMP2 Locus of Epstein-Barr Virus by Mutation of a Single CTCF-Cohesin Binding Site , 2013, Journal of Virology.

[4]  E. Johannsen,et al.  Epigenetics of human papillomaviruses. , 2013, Virology.

[5]  J. Lieb,et al.  The Open Chromatin Landscape of Kaposi's Sarcoma-Associated Herpesvirus , 2013, Journal of Virology.

[6]  L. Banks,et al.  The Role of Protein Kinase A Regulation of the E6 PDZ-Binding Domain during the Differentiation-Dependent Life Cycle of Human Papillomavirus Type 18 , 2013, Journal of Virology.

[7]  Jay Shendure,et al.  The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line , 2013, Nature.

[8]  T. R. Broker,et al.  HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures , 2013, Proceedings of the National Academy of Sciences.

[9]  P. Lieberman,et al.  CTCF Regulates Kaposi's Sarcoma-Associated Herpesvirus Latency Transcription by Nucleosome Displacement and RNA Polymerase Programming , 2012, Journal of Virology.

[10]  Wim Quint,et al.  The biology and life-cycle of human papillomaviruses. , 2012, Vaccine.

[11]  E. Androphy,et al.  Acetylation of Conserved Lysines in Bovine Papillomavirus E2 by p300 , 2012, Journal of Virology.

[12]  Vivek Gopalan,et al.  The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis , 2012, Nucleic Acids Res..

[13]  Matthew T. Maurano,et al.  Widespread plasticity in CTCF occupancy linked to DNA methylation , 2012, Genome research.

[14]  Hebing Chen,et al.  Comprehensive Identification and Annotation of Cell Type-Specific and Ubiquitous CTCF-Binding Sites in the Human Genome , 2012, PloS one.

[15]  D. Pim,et al.  HPV‐16 E2 contributes to induction of HPV‐16 late gene expression by inhibiting early polyadenylation , 2012, The EMBO journal.

[16]  P. Lieberman,et al.  Cohesins Repress Kaposi's Sarcoma-Associated Herpesvirus Immediate Early Gene Transcription during Latency , 2012, Journal of Virology.

[17]  L. Laimins,et al.  Differentiation-Dependent Changes in Levels of C/EBPβ Repressors and Activators Regulate Human Papillomavirus Type 31 Late Gene Expression , 2012, Journal of Virology.

[18]  Michael D. Wilson,et al.  Waves of Retrotransposon Expansion Remodel Genome Organization and CTCF Binding in Multiple Mammalian Lineages , 2012, Cell.

[19]  R. Sandberg,et al.  CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing , 2011, Nature.

[20]  P. Lieberman,et al.  Coordination of KSHV Latent and Lytic Gene Control by CTCF-Cohesin Mediated Chromosome Conformation , 2011, PLoS pathogens.

[21]  I. Tempera,et al.  EBV Latency Types Adopt Alternative Chromatin Conformations , 2011, PLoS pathogens.

[22]  L. Chow,et al.  Construction of a Full Transcription Map of Human Papillomavirus Type 18 during Productive Viral Infection , 2011, Journal of Virology.

[23]  S. Roberts,et al.  A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression. , 2011, Virology.

[24]  Judith Nedrow Production JOURNAL OF VIROLOGY , 2011, Journal of Virology.

[25]  I. Tempera,et al.  CTCF Prevents the Epigenetic Drift of EBV Latency Promoter Qp , 2010, PLoS pathogens.

[26]  D. Lim,et al.  HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma. , 2010, Cancer research.

[27]  M. Stanley,et al.  In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis. , 2010, Cancer research.

[28]  M. McFarlane,et al.  RNA splicing factors regulated by HPV16 during cervical tumour progression , 2009, The Journal of pathology.

[29]  V. Corces,et al.  CTCF: Master Weaver of the Genome , 2009, Cell.

[30]  F. Thierry Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. , 2009, Virology.

[31]  L. Chow,et al.  Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. , 2009, Genes & development.

[32]  E. Androphy,et al.  Tax1BP1 Interacts with Papillomavirus E2 and Regulates E2-Dependent Transcription and Stability , 2008, Journal of Virology.

[33]  S. Graham,et al.  Human Papillomavirus Type 16 E2 Protein Transcriptionally Activates the Promoter of a Key Cellular Splicing Factor, SF2/ASF , 2008, Journal of Virology.

[34]  H. Bernard,et al.  Effects of cellular differentiation, chromosomal integration and 5-aza-2'-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. , 2008, Virology.

[35]  L. Laimins,et al.  Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding. , 2008, Virology.

[36]  L. Chow,et al.  Casein Kinase II Motif-Dependent Phosphorylation of Human Papillomavirus E7 Protein Promotes p130 Degradation and S-Phase Induction in Differentiated Human Keratinocytes , 2008, Journal of Virology.

[37]  G. Felsenfeld,et al.  Critical DNA Binding Interactions of the Insulator Protein CTCF , 2007, Journal of Biological Chemistry.

[38]  Sally Roberts,et al.  The full-length E1E4 protein of human papillomavirus type 18 modulates differentiation-dependent viral DNA amplification and late gene expression. , 2007, Virology.

[39]  T. Mikkelsen,et al.  Systematic discovery of regulatory motifs in conserved regions of the human genome, including thousands of CTCF insulator sites , 2007, Proceedings of the National Academy of Sciences.

[40]  Michael Q. Zhang,et al.  Analysis of the Vertebrate Insulator Protein CTCF-Binding Sites in the Human Genome , 2007, Cell.

[41]  P. Lieberman,et al.  Regulation of Epstein-Barr Virus Latency Type by the Chromatin Boundary Factor CTCF , 2006, Journal of Virology.

[42]  A. Roman The Human Papillomavirus E7 Protein Shines a Spotlight on the pRB Family Member, p130 , 2006, Cell cycle.

[43]  M. Stanley,et al.  Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[44]  T. Kanda,et al.  CCAAT/enhancer binding protein β binds to and activates the P670 promoter of human papillomavirus type 16 , 2006 .

[45]  Benyue Zhang,et al.  The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[46]  L. Laimins,et al.  Role of the E1∧E4 Protein in the Differentiation-Dependent Life Cycle of Human Papillomavirus Type 31 , 2005, Journal of Virology.

[47]  L. Laimins,et al.  Induction of the Human Papillomavirus Type 31 Late Promoter Requires Differentiation but Not DNA Amplification , 2005, Journal of Virology.

[48]  P. Howley,et al.  Interaction of the Bovine Papillomavirus E2 Protein with Brd4 Tethers the Viral DNA to Host Mitotic Chromosomes , 2004, Cell.

[49]  S. Franceschi,et al.  Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis , 2003, British Journal of Cancer.

[50]  S. Roberts,et al.  The ND10 Component Promyelocytic Leukemia Protein Relocates to Human Papillomavirus Type 1 E4 Intranuclear Inclusion Bodies in Cultured Keratinocytes and in Warts , 2003, Journal of Virology.

[51]  Tom Freeman,et al.  Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. , 2002, Cancer research.

[52]  G. Reynolds,et al.  Changes in expression of the human homologue of the Drosophila discs large tumour suppressor protein in high-grade premalignant cervical neoplasias. , 2002, Carcinogenesis.

[53]  A. West,et al.  Conserved CTCF Insulator Elements Flank the Mouse and Human β-Globin Loci , 2002, Molecular and Cellular Biology.

[54]  P. Neiman,et al.  Negative Transcriptional Regulation Mediated by Thyroid Hormone Response Element 144 Requires Binding of the Multivalent Factor CTCF to a Novel Target DNA Sequence* , 1999, The Journal of Biological Chemistry.

[55]  A. West,et al.  The Protein CTCF Is Required for the Enhancer Blocking Activity of Vertebrate Insulators , 1999, Cell.

[56]  F. Stubenrauch,et al.  Activation of Papillomavirus Late Gene Transcription and Genome Amplification upon Differentiation in Semisolid Medium Is Coincident with Expression of Involucrin and Transglutaminase but Not Keratin-10 , 1998, Journal of Virology.

[57]  Victor V Lobanenkov,et al.  Molecular weight abnormalities of the CTCF transcription factor: CTCF migrates aberrantly in SDS-PAGE and the size of the expressed protein is affected by the UTRs and sequences within the coding region of the CTCF gene. , 1997, Nucleic acids research.

[58]  P. Neiman,et al.  An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes , 1996, Molecular and cellular biology.

[59]  M. O’Connor,et al.  Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. , 1995, Virology.

[60]  H. Bernard,et al.  The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID , 1994, Journal of virology.

[61]  M. Yaniv,et al.  Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure. , 1994, The EMBO journal.

[62]  T. Crook,et al.  Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation , 1993, Journal of virology.

[63]  P. Howley,et al.  Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes , 1992, Journal of virology.

[64]  B. Gloss,et al.  During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. , 1992, Nucleic acids research.

[65]  R. Tjian,et al.  Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription , 1991, Cell.

[66]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[67]  J. Dillner,et al.  Induction of bovine papillomavirus E2 gene expression and early region transcription by cell growth arrest: correlation with viral DNA amplification and evidence for differential promoter induction , 1990, Journal of virology.

[68]  P. Howley,et al.  Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters , 1990, Journal of virology.

[69]  M. Yaniv,et al.  The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes , 1989, Journal of virology.

[70]  M. Stanley,et al.  Properties of a non‐tumorigenic human cervical keratinocyte cell line , 1989, International journal of cancer.

[71]  K. Münger,et al.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.

[72]  T. R. Broker,et al.  Identification and mapping of human papillomavirus type 1 RNA transcripts recovered from plantar warts and infected epithelial cell cultures , 1987, Journal of virology.

[73]  T. Kanda,et al.  CCAAT/enhancer binding protein beta binds to and activates the P670 promoter of human papillomavirus type 16. , 2006, Virology.

[74]  A. West,et al.  Conserved CTCF insulator elements flank the mouse and human beta-globin loci. , 2002, Molecular and cellular biology.